CWM
IDYA icon

CarsonAllaria Wealth Management’s IDEAYA Biosciences IDYA Stock Holding History

CarsonAllaria Wealth Management’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-285
Closed -$4K – 354
2022
Q3 		$4K Hold
285
– – ﹤0.01% 240
2022
Q2 		$4K Hold
285
– – ﹤0.01% 243
2022
Q1 		$3K Hold
285
– – ﹤0.01% 284
2021
Q4 		$7K Buy
+285
New +$6.62K 0.01% 234

Other funds holding IDYA

LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
CPX
Canaan Partners X Menlo Park, California $74.7M AUM 151.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

CarsonAllaria Wealth Management's IDYA Position: Q4 2022 in Review

CarsonAllaria Wealth Management sold out of IDEAYA Biosciences (IDYA) in Q4 2022, closing a stake of 285 shares — an estimated $4K sold.

CarsonAllaria Wealth Management first reported a position in IDYA in Q4 2021 and held it in 4 quarters. The position peaked at $7K in Q4 2021. 117 funds tracked by Wall St. Rank hold IDYA as of Q4 2022.

  • CarsonAllaria Wealth Management reported no remaining IDEAYA Biosciences position as of Q4 2022 after selling out during the quarter.
  • CarsonAllaria Wealth Management sold 285 IDEAYA Biosciences shares in Q4 2022, an estimated $4K.
  • CarsonAllaria Wealth Management first reported a position in IDEAYA Biosciences in Q4 2021 and held it in 4 quarters.
  • CarsonAllaria Wealth Management's IDEAYA Biosciences position peaked at $7K in Q4 2021.
  • 117 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q4 2022.

Based on CarsonAllaria Wealth Management's 13F filing for Q4 2022, filed 6 Feb 2023.